Please wait while the formulary information is being retrieved.
COTELLIC (COBIMETINIB FUMARATE)
- Malignant melanoma with BRAF v600E mutation
- Malignant melanoma with BRAF v600K mutation
20 mg tablet
- 3 tablets (60 mg) by oral route once daily on days 1-21 of a 28 day treatment cycle
Malignant melanoma with BRAF v600E mutation
- 3 tablets (60 mg) by oral route once daily on days 1-21 of a 28 day treatment cycle
Malignant melanoma with BRAF v600K mutation
- 3 tablets (60 mg) by oral route once daily on days 1-21 of a 28 day treatment cycle
- None
Contraindicated
- Atripla
- B cplx-C-St.Johnwrt-K.&S.ginsg
- Belladonna-phenobarbital
- bosentan
- calcium-mag-B complex-D3-hrb61
- carbamazepine
- Carbatrol
- Cerebyx
- Cold & Flu Fighter
- dabrafenib
- dexamethasone
- Dexamethasone Intensol
- dexamethasone sodium phos (PF)
- dexamethasone sodium phosphate
- Dexpak 10 Day
- Dexpak 13 Day
- Dexpak 6 Day
- Dilantin
- Dilantin Extended
- Dilantin Infatabs
- Dilantin Kapseal
- Dilantin-125
- Donnatal
- efavirenz
- efavirenz-emtricitabin-tenofov
- enzalutamide
- Epitol
- Equetro
- etravirine
- Fatigue Relief Complex
- fosphenytoin
- Intelence
- isoniazid-rifamp-pyrazinamide
- Luminal
- modafinil
- Mysoline
- nafcillin
- nafcillin in dextrose iso-osm
- phenobarb-hyoscy-atropine-scop
- phenobarbital
- phenobarbital sodium
- Phenytek
- phenytoin
- phenytoin sodium
- phenytoin sodium extended
- Priftin
- primidone
- Provigil
- Rifadin
- Rifamate
- rifampin
- rifampin-isoniazid
- rifapentine
- Rifater
- St. John's wort
- Sustiva
- Tafinlar
- Tegretol
- Tegretol Xr
- Tracleer
- vit C-St. John wort-elder-hb30
- Women's Complex
- Xtandi
Severe
Moderate
- None
- Lactating mother
- Retinal vascular occlusion
Contraindicated
- Chronic heart failure
- Diabetic retinopathy
- Hemorrhage
- Hypertensive retinopathy
- Myopathy with CK elevation
- Pregnancy
- Retinal detachment
Severe
Moderate
- Abnormal hepatic function tests
COTELLIC (COBIMETINIB FUMARATE)
- Malignant melanoma with BRAF v600E mutation
- Malignant melanoma with BRAF v600K mutation
- Abnormal hepatic function tests
- Hemorrhage
- Increased alanine transaminase
- Increased aspartate transaminase
- Diarrhea
- Fever
- Hyponatremia
- Hypophosphatemia
- Increased creatine kinase level
- Lymphopenia
- Nausea
- Skin photosensitivity
- Vomiting
More Frequent
Severe
Less Severe
- Anemia
- Basal cell carcinoma of skin
- Cardiomyopathy
- Hepatitis
- Hyperbilirubinemia
- Hyperkalemia
- Hypocalcemia
- Hypokalemia
- Keratoacanthoma
- Retinal detachment
- Retinal disorder
- Skin rash
- Squamous cell carcinoma
- Vision loss
- Chills
- Stomatitis
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Interstitial pneumonitis
- Pulmonary hemorrhage
- Retinal vascular occlusion
- Rhabdomyolysis
- Second primary melanoma
- Stevens-johnson syndrome
Less Severe
- None
Contraindicated
None
Severe Precaution
Cobimetinib
Safety and efficacy not established.
- 1 Day – 18 Years
- Safety and efficacy not established.
Management or Monitoring Precaution
None
Cobimetinib
- Severity Level:
D
- Additional Notes: Based on drug pharmacology developmental toxicity is possible.
Contraindicated
Cobimetinib
Mfg rec hold breastfeeding during and 2 wks after last dose
General | Excretion Potential | Effect on Infant | Notes |
Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Mfg rec hold breastfeeding during and 2 wks after last dose |
Precaution Exists
None
General | Excretion Potential | Effect on Infant | Notes |
None |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Malignant melanoma with BRAF v600E mutation | |
C43 | Malignant melanoma of skin |
C43.0 | Malignant melanoma of lip |
C43.1 | Malignant melanoma of eyelid, including canthus |
C43.10 | Malignant melanoma of unspecified eyelid, including canthus |
C43.11 | Malignant melanoma of right eyelid, including canthus |
C43.111 | Malignant melanoma of right upper eyelid, including canthus |
C43.112 | Malignant melanoma of right lower eyelid, including canthus |
C43.12 | Malignant melanoma of left eyelid, including canthus |
C43.121 | Malignant melanoma of left upper eyelid, including canthus |
C43.122 | Malignant melanoma of left lower eyelid, including canthus |
C43.2 | Malignant melanoma of ear and external auricular canal |
C43.20 | Malignant melanoma of unspecified ear and external auricular canal |
C43.21 | Malignant melanoma of right ear and external auricular canal |
C43.22 | Malignant melanoma of left ear and external auricular canal |
C43.3 | Malignant melanoma of other and unspecified parts of face |
C43.30 | Malignant melanoma of unspecified part of face |
C43.31 | Malignant melanoma of nose |
C43.39 | Malignant melanoma of other parts of face |
C43.4 | Malignant melanoma of scalp and neck |
C43.5 | Malignant melanoma of trunk |
C43.51 | Malignant melanoma of anal skin |
C43.52 | Malignant melanoma of skin of breast |
C43.59 | Malignant melanoma of other part of trunk |
C43.6 | Malignant melanoma of upper limb, including shoulder |
C43.60 | Malignant melanoma of unspecified upper limb, including shoulder |
C43.61 | Malignant melanoma of right upper limb, including shoulder |
C43.62 | Malignant melanoma of left upper limb, including shoulder |
C43.7 | Malignant melanoma of lower limb, including hip |
C43.70 | Malignant melanoma of unspecified lower limb, including hip |
C43.71 | Malignant melanoma of right lower limb, including hip |
C43.72 | Malignant melanoma of left lower limb, including hip |
C43.8 | Malignant melanoma of overlapping sites of skin |
C43.9 | Malignant melanoma of skin, unspecified |
Malignant melanoma with BRAF v600K mutation | |
C43 | Malignant melanoma of skin |
C43.0 | Malignant melanoma of lip |
C43.1 | Malignant melanoma of eyelid, including canthus |
C43.10 | Malignant melanoma of unspecified eyelid, including canthus |
C43.11 | Malignant melanoma of right eyelid, including canthus |
C43.111 | Malignant melanoma of right upper eyelid, including canthus |
C43.112 | Malignant melanoma of right lower eyelid, including canthus |
C43.12 | Malignant melanoma of left eyelid, including canthus |
C43.121 | Malignant melanoma of left upper eyelid, including canthus |
C43.122 | Malignant melanoma of left lower eyelid, including canthus |
C43.2 | Malignant melanoma of ear and external auricular canal |
C43.20 | Malignant melanoma of unspecified ear and external auricular canal |
C43.21 | Malignant melanoma of right ear and external auricular canal |
C43.22 | Malignant melanoma of left ear and external auricular canal |
C43.3 | Malignant melanoma of other and unspecified parts of face |
C43.30 | Malignant melanoma of unspecified part of face |
C43.31 | Malignant melanoma of nose |
C43.39 | Malignant melanoma of other parts of face |
C43.4 | Malignant melanoma of scalp and neck |
C43.5 | Malignant melanoma of trunk |
C43.51 | Malignant melanoma of anal skin |
C43.52 | Malignant melanoma of skin of breast |
C43.59 | Malignant melanoma of other part of trunk |
C43.6 | Malignant melanoma of upper limb, including shoulder |
C43.60 | Malignant melanoma of unspecified upper limb, including shoulder |
C43.61 | Malignant melanoma of right upper limb, including shoulder |
C43.62 | Malignant melanoma of left upper limb, including shoulder |
C43.7 | Malignant melanoma of lower limb, including hip |
C43.70 | Malignant melanoma of unspecified lower limb, including hip |
C43.71 | Malignant melanoma of right lower limb, including hip |
C43.72 | Malignant melanoma of left lower limb, including hip |
C43.8 | Malignant melanoma of overlapping sites of skin |
C43.9 | Malignant melanoma of skin, unspecified |
0-9 | A-Z |
---|---|
C43 | Malignant melanoma of skin |
C43 | Malignant melanoma of skin |
C43.0 | Malignant melanoma of lip |
C43.0 | Malignant melanoma of lip |
C43.1 | Malignant melanoma of eyelid, including canthus |
C43.1 | Malignant melanoma of eyelid, including canthus |
C43.10 | Malignant melanoma of unspecified eyelid, including canthus |
C43.10 | Malignant melanoma of unspecified eyelid, including canthus |
C43.11 | Malignant melanoma of right eyelid, including canthus |
C43.11 | Malignant melanoma of right eyelid, including canthus |
C43.111 | Malignant melanoma of right upper eyelid, including canthus |
C43.111 | Malignant melanoma of right upper eyelid, including canthus |
C43.112 | Malignant melanoma of right lower eyelid, including canthus |
C43.112 | Malignant melanoma of right lower eyelid, including canthus |
C43.12 | Malignant melanoma of left eyelid, including canthus |
C43.12 | Malignant melanoma of left eyelid, including canthus |
C43.121 | Malignant melanoma of left upper eyelid, including canthus |
C43.121 | Malignant melanoma of left upper eyelid, including canthus |
C43.122 | Malignant melanoma of left lower eyelid, including canthus |
C43.122 | Malignant melanoma of left lower eyelid, including canthus |
C43.2 | Malignant melanoma of ear and external auricular canal |
C43.2 | Malignant melanoma of ear and external auricular canal |
C43.20 | Malignant melanoma of unspecified ear and external auricular canal |
C43.20 | Malignant melanoma of unspecified ear and external auricular canal |
C43.21 | Malignant melanoma of right ear and external auricular canal |
C43.21 | Malignant melanoma of right ear and external auricular canal |
C43.22 | Malignant melanoma of left ear and external auricular canal |
C43.22 | Malignant melanoma of left ear and external auricular canal |
C43.3 | Malignant melanoma of other and unspecified parts of face |
C43.3 | Malignant melanoma of other and unspecified parts of face |
C43.30 | Malignant melanoma of unspecified part of face |
C43.30 | Malignant melanoma of unspecified part of face |
C43.31 | Malignant melanoma of nose |
C43.31 | Malignant melanoma of nose |
C43.39 | Malignant melanoma of other parts of face |
C43.39 | Malignant melanoma of other parts of face |
C43.4 | Malignant melanoma of scalp and neck |
C43.4 | Malignant melanoma of scalp and neck |
C43.5 | Malignant melanoma of trunk |
C43.5 | Malignant melanoma of trunk |
C43.51 | Malignant melanoma of anal skin |
C43.51 | Malignant melanoma of anal skin |
C43.52 | Malignant melanoma of skin of breast |
C43.52 | Malignant melanoma of skin of breast |
C43.59 | Malignant melanoma of other part of trunk |
C43.59 | Malignant melanoma of other part of trunk |
C43.6 | Malignant melanoma of upper limb, including shoulder |
C43.6 | Malignant melanoma of upper limb, including shoulder |
C43.60 | Malignant melanoma of unspecified upper limb, including shoulder |
C43.60 | Malignant melanoma of unspecified upper limb, including shoulder |
C43.61 | Malignant melanoma of right upper limb, including shoulder |
C43.61 | Malignant melanoma of right upper limb, including shoulder |
C43.62 | Malignant melanoma of left upper limb, including shoulder |
C43.62 | Malignant melanoma of left upper limb, including shoulder |
C43.7 | Malignant melanoma of lower limb, including hip |
C43.7 | Malignant melanoma of lower limb, including hip |
C43.70 | Malignant melanoma of unspecified lower limb, including hip |
C43.70 | Malignant melanoma of unspecified lower limb, including hip |
C43.71 | Malignant melanoma of right lower limb, including hip |
C43.71 | Malignant melanoma of right lower limb, including hip |
C43.72 | Malignant melanoma of left lower limb, including hip |
C43.72 | Malignant melanoma of left lower limb, including hip |
C43.8 | Malignant melanoma of overlapping sites of skin |
C43.8 | Malignant melanoma of overlapping sites of skin |
C43.9 | Malignant melanoma of skin, unspecified |
C43.9 | Malignant melanoma of skin, unspecified |
Formulary Reference Tool